Subcutaneous Facial Nodules Developing After Treatment With Ruxolitinib: Challenge.

Jakafi (ruxolitinib) - Incyte

http://www.ncbi.nlm.nih.gov/pubmed/42758891

Eduardo Rozas-Muñoz; Jaime Piquero-Casals; Juan-Andres Madariaga; Nelson Ramos Arancibia

Sep 19, 2026